BACKGROUND AND AIMS: Genetic predisposition for inflammatory bowel disease (IBD) has been demonstrated by epidemiological and genetic linkage studies. Genetic linkage of IBD to chromosome 3 has been observed previously. A high density analysis of chromosome 3p was performed to confirm prior linkages and elucidate potential genetic associations. METHODS: Forty three microsatellite markers on chromosome 3 were genotyped in 353 affected sibling pairs of North European Caucasian extraction (average marker density 2 cM in the linkage interval). Marker order was defined by genetic and radiation hybrid techniques. RESULTS: The maximum single point logarithm of odds (LOD) score was observed for Crohn's disease at D3S3591. Peak multipoint LOD scores of 1.65 and 1.40 for the IBD phenotype were observed near D3S1304 (distal 3p) and near D3S1283 in the linkage region previously reported. Crohn's disease contributed predominantly to the linkage. The transmission disequilibrium test showed significant evidence of association (p=0.009) between allele 4 of D3S1076 and the IBD phenotype (51 transmitted v 28 non-transmitted). Two known polymorphisms in the CCR2 and CCR5 genes were analysed, neither of which showed significant association with IBD. Additional haplotype associations were observed in the vicinity of D3S1076. CONCLUSIONS: This study provides confirmatory linkage evidence for an IBD susceptibility locus on chromosome 3p and suggests that CCR2 and CCR5 are unlikely to be major susceptibility loci for IBD. The association findings in this region warrant further investigation.
BACKGROUND AND AIMS: Genetic predisposition for inflammatory bowel disease (IBD) has been demonstrated by epidemiological and genetic linkage studies. Genetic linkage of IBD to chromosome 3 has been observed previously. A high density analysis of chromosome 3p was performed to confirm prior linkages and elucidate potential genetic associations. METHODS: Forty three microsatellite markers on chromosome 3 were genotyped in 353 affected sibling pairs of North European Caucasian extraction (average marker density 2 cM in the linkage interval). Marker order was defined by genetic and radiation hybrid techniques. RESULTS: The maximum single point logarithm of odds (LOD) score was observed for Crohn's disease at D3S3591. Peak multipoint LOD scores of 1.65 and 1.40 for the IBD phenotype were observed near D3S1304 (distal 3p) and near D3S1283 in the linkage region previously reported. Crohn's disease contributed predominantly to the linkage. The transmission disequilibrium test showed significant evidence of association (p=0.009) between allele 4 of D3S1076 and the IBD phenotype (51 transmitted v 28 non-transmitted). Two known polymorphisms in the CCR2 and CCR5 genes were analysed, neither of which showed significant association with IBD. Additional haplotype associations were observed in the vicinity of D3S1076. CONCLUSIONS: This study provides confirmatory linkage evidence for an IBD susceptibility locus on chromosome 3p and suggests that CCR2 and CCR5 are unlikely to be major susceptibility loci for IBD. The association findings in this region warrant further investigation.
Authors: V Annese; A Latiano; P Bovio; P Forabosco; A Piepoli; G Lombardi; A Andreoli; M Astegiano; P Gionchetti; G Riegler; G C Sturniolo; M Clementi; E Rappaport; P Fortina; M Devoto; P Gasparini; A Andriulli Journal: Eur J Hum Genet Date: 1999-07 Impact factor: 4.246
Authors: S R Brant; Y Fu; C T Fields; R Baltazar; G Ravenhill; M R Pickles; P M Rohal; J Mann; B S Kirschner; E W Jabs; T M Bayless; S B Hanauer; J H Cho Journal: Gastroenterology Date: 1998-11 Impact factor: 22.682
Authors: J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber Journal: Am J Hum Genet Date: 1999-12 Impact factor: 11.025
Authors: M G Olavesen; J Hampe; M M Mirza; R Saiz; C M Lewis; S Bridger; D Teare; D F Easton; T Herrmann; G Scott; J Hirst; J Sanderson; S V Hodgson; J Lee; A MacPherson; S Schreiber; J E Lennard-Jones; M E Curran; C G Mathew Journal: Immunogenetics Date: 2000-01 Impact factor: 2.846
Authors: X Ye; P Mehlen; S Rabizadeh; T VanArsdale; H Zhang; H Shin; J J Wang; E Leo; J Zapata; C A Hauser; J C Reed; D E Bredesen Journal: J Biol Chem Date: 1999-10-15 Impact factor: 5.157
Authors: K M Lammers; S Ouburg; S A Morré; J B A Crusius; P Gionchett; F Rizzello; C Morselli; E Caramelli; R Conte; G Poggioli; M Campieri; A S Peña Journal: World J Gastroenterol Date: 2005-12-14 Impact factor: 5.742
Authors: Theresa T Pizarro; Luca Pastorelli; Giorgos Bamias; Rekha R Garg; Brian K Reuter; Joseph R Mercado; Marcello Chieppa; Kristen O Arseneau; Klaus Ley; Fabio Cominelli Journal: Inflamm Bowel Dis Date: 2011-05-06 Impact factor: 5.325
Authors: P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux Journal: Mucosal Immunol Date: 2008-01-16 Impact factor: 7.313
Authors: S Vermeire; P Rutgeerts; K Van Steen; S Joossens; G Claessens; M Pierik; M Peeters; R Vlietinck Journal: Gut Date: 2004-07 Impact factor: 23.059